Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma - Yahoo Finance Australia | "marketing" - Google News | September 07, 2020 at 05:02AM
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma Yahoo Finance Australia
September 07, 2020 at 05:02AM | "marketing" - Google News
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma - Yahoo Finance Australia
"marketing" - Google News
Nenhum comentário:
Postar um comentário